Company Snapshot: Nemaura Medical Inc.

NMRD
Last	Change	Volume	High	Low

Company Overview

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes specialty medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. The company was founded in 2009 and is headquartered in Loughborough, the United Kingdom.

Client News

1. Aug 15 2022 Nemaura Medical Reports Fiscal First Quarter 2023 Results and Provides Business Update
2. Jul 21 2022 Nemaura Medical Granted UK Trademark “Meta Score,” a Digital Biomarker Term for its Metabolic Health Program
3. Jun 30 2022 Nemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2022
4. May 23 2022 Nemaura Medical Strengthens Balance Sheet with Further Non-Dilutive Funding